Education, industry news, and insights on peptide therapy and regenerative health
The peptide industry is experiencing record consolidation in 2026, with over $4.2 billion in acquisitions reshaping the market. Understanding these changes is critical for patients and providers navigating the evolving landscape.
Jun 13, 2026
The Peptide Alliance welcomes Hydro Research of Milwaukee as its first Featured Partner — a supplier with 170+ public third-party lab documents backing a 99%+ purity promise.
Jun 12, 2026
Comprehensive analysis of 2026 peptide industry trends including AI-powered drug discovery, novel delivery systems, regulatory evolution, and market consolidation reshaping the therapeutic landscape.
Jun 10, 2026
Comprehensive 2026 update on peptide therapy insurance coverage including Medicare, private plans, HSA/FSA eligibility, and strategies for maximizing reimbursement.
Jun 8, 2026
A comprehensive breakdown of 2026 compounding pharmacy peptide regulations, recent enforcement actions, what's legally compoundable, and how to stay compliant with federal and state requirements.
May 28, 2026
Comprehensive analysis of the ongoing semaglutide shortage in 2026, exploring supply chain issues, compounding alternatives, insurance coverage, and practical guidance for patients seeking GLP-1 peptide therapy.
May 25, 2026
The GLP-1 and broader peptide therapy market has exploded from $6B to $50+B since 2020. This comprehensive analysis examines current market dynamics, supply chain developments, regulatory evolution, and industry projections through 2030.
May 24, 2026
Complete guide to peptide regulation in Canada in 2026, covering legal status, compounding pharmacy rules, provincial variations, and how to access peptides safely and legally.
May 13, 2026
Research peptides exist in a legal gray zone. Understand FDA regulations, the difference between research-grade and prescription peptides, and how to access peptides legally in 2026.
May 6, 2026
A comprehensive 2026 guide to peptide therapy insurance coverage, reimbursement strategies, and navigating the complex landscape of which peptides are covered and how to maximize benefits.
May 1, 2026
Understanding the 2026 FDA peptide regulatory landscape—what's changed for compounding pharmacies, clinics, and patients seeking safe, legal access to peptide therapies.
Apr 16, 2026